Core Scientific Reports Warrant Exercises

TL;DR

CORE warrants exercised, watch share count!

AI Summary

On June 25, 2024, Core Scientific, Inc. filed an 8-K to report on the exercise of warrants. The company announced that certain warrants with an exercise price of $6.81 per share and others with an exercise price of $0.01 per share were exercised on June 25, 2024. This filing is related to the company's financial operations and warrant management.

Why It Matters

The exercise of warrants can impact the company's outstanding share count and potentially provide additional capital, affecting its financial structure.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of warrant exercises and does not indicate any new or significant risks.

Key Numbers

• $6.81 — Warrant Exercise Price (One of the exercise prices for warrants exercised on June 25, 2024.)
• $0.01 — Warrant Exercise Price (Another exercise price for warrants exercised on June 25, 2024.)

Key Players & Entities

• Core Scientific, Inc. (company) — Registrant
• June 25, 2024 (date) — Date of Report
• $6.81 (dollar_amount) — Warrant Exercise Price
• $0.01 (dollar_amount) — Warrant Exercise Price

FAQ

Key Financial Figures

• $0.00001 — ich registered Common stock, par value $0.00001 per share CORZ The Nasdaq Global Selec
• $6.81 — of common stock at an exercise price of $6.81 per share CORZW The Nasdaq Global Sel
• $0.01 — of common stock at an exercise price of $0.01 per share CORZZ The Nasdaq Global Sel

Filing Documents

• core-20240625.htm (8-K) — 40KB
• ex991-finalcorzhpcoptionre.htm (EX-99.1) — 21KB
• image_0a.jpg (GRAPHIC) — 25KB
• 0001628280-24-029900.txt ( ) — 282KB
• core-20240625.xsd (EX-101.SCH) — 3KB
• core-20240625_def.xml (EX-101.DEF) — 17KB
• core-20240625_lab.xml (EX-101.LAB) — 30KB
• core-20240625_pre.xml (EX-101.PRE) — 17KB
• core-20240625_htm.xml (XML) — 5KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On June 25, 2024, Core Scientific, Inc. (the "Company") issued a press release announcing CoreWeave, Inc., the AI Hyperscaler, had exercised its first option to contract for additional infrastructure under the terms of its 200MW 12-year high-performance compute hosting contracts previously announced on June 3, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by reference. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before, on or after the date hereof, regardless of any general incorporation language except as expressly set forth by specific reference in such filing. Cautionary Note Regarding Forward-Looking Statements This Current Report on Form 8-K includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "aim," "estimate," "plan," "project," "forecast," "opportunity," "goal," "intend," "will," "expect," "anticipate," "believe," "seek," "target," "potential," "hope" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These statements include, but are not limited, statements regarding potential benefits of or expectations regarding the strategic relationship, agreements and contemplated transactions with CoreWeave, impacts on the Company's revenue, financial and other operating results, completion and timing of certain events, impacts on the Company's trading multi

01 Financial Statement and Exhibits

Item 9.01 Financial Statement and Exhibits (d) Exhibits: Exhibit No. Description 99.1* Press Release dated June 25 , 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * The information contained in this exhibit is furnished but not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Scientific, Inc. Dated: June 25, 2024 By: /s/ Todd M. DuChene Name: Todd M. DuChene Title: Chief Legal Officer and Chief Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR